Tri Locum Partners »

Lyra Therapeutics shares owned by Tri Locum Partners

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.1M 979k 6.22

More positions owned by Tri Locum Partners

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Silk Road Medical Inc Common (SILK)
Natera (NTRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Legend Biotech Corp Sponsored Ads (LEGN)
Merck & Co (MRK)
Vertex Pharmaceuticals Incorporated (VRTX)
Madrigal Pharmaceuticals (MDGL)
Baxter International (BAX)
Merus N V (MRUS)
Tandem Diabetes Care Com New (TNDM)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Regeneron Pharmaceuticals (REGN)

View all positions for Tri Locum Partners

Top funds holding Lyra Therapeutics

Perceptive Advisors
Citadel Advisors
Nantahala Capital Management
Samsara BioCapital
Point72 Asset Management
VR Adviser
Vanguard Group
Pura Vida Investments
Rosalind Advisors
Ikarian Capital
Tri Locum Partners
Verition Fund Management
Laurion Capital Management
Woodline Partners
Parkman Healthcare Partners

View all funds holding Lyra Therapeutics